COVID-19 Severity and Waning Immunity After up to 4 mRNA Vaccine Doses in 73 608 Patients With Cancer and 621 475 Matched Controls in Singapore: A Nationwide Cohort Study

IMPORTANCE: Despite patients with cancer being at risk of poor outcomes from COVID-19, there are few published studies for vaccine efficacy in this group, with suboptimal immunogenicity and waning vaccine efficacy described in small studies being a concern. OBJECTIVE: To assess the incidence rate of...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Wei Chong, Tan, Janice Yu Jin, Lim, Joline Si Jing, Tan, Ryan Ying Cong, Lee, Ainsley Ryan Yan Bin, Leong, Fun Loon, Lee, Soo Chin, Chai, Louis Yi Ann, Tan, Thuan Tong, Malek, Muhammad Ismail Bin Abdul, Ong, Benjamin, Lye, David Chien, Chiew, Calvin J., Chng, Wee Joo, Lim, Soon Thye, Bharwani, Lavina D., Tan, Iain Beehuat, Sundar, Raghav, Tan, Kelvin Bryan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10346511/
https://www.ncbi.nlm.nih.gov/pubmed/37440245
http://dx.doi.org/10.1001/jamaoncol.2023.2271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10346511/
https://www.ncbi.nlm.nih.gov/pubmed/37440245
http://dx.doi.org/10.1001/jamaoncol.2023.2271

Ejemplares similares